Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Avalon Globocare's share price for the quarter that ended in Dec. 2023 was $0.483. Avalon Globocare's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 11.00 Mil. Therefore, Avalon Globocare's market cap for the quarter that ended in Dec. 2023 was $5.31 Mil.
Avalon Globocare's quarterly market cap
declined
from Jun. 2023 ($16.09 Mil) to Sep. 2023 ($8.77 Mil) and
declined
from Sep. 2023 ($8.77 Mil) to Dec. 2023 ($5.31 Mil).
Avalon Globocare's annual market cap
declined
from Dec. 2021 ($72.53 Mil) to Dec. 2022 ($51.80 Mil) and
declined
from Dec. 2022 ($51.80 Mil) to Dec. 2023 ($5.31 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Avalon Globocare's Enterprise Value for Today is $31.50 Mil.
Avalon Globocare Market Cap Historical Data
The historical data trend for Avalon Globocare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Avalon Globocare's Market Cap
For the Real Estate Services subindustry, Avalon Globocare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avalon Globocare's Market Cap Distribution in the Real Estate Industry
For the Real Estate industry and Real Estate sector, Avalon Globocare's Market Cap distribution charts can be found below:
* The bar in red indicates where Avalon Globocare's Market Cap falls into.
Avalon Globocare Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Avalon Globocare's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avalon Globocare (NAS:ALBT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Avalon Globocare Market Cap Related Terms
Thank you for viewing the detailed overview of Avalon Globocare's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Avalon Globocare (Avalon Globocare) Business Description
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. It has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALBT has been successfully added to your 